These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 8286741)
1. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Kreitman RJ; Bailon P; Chaudhary VK; FitzGerald DJ; Pastan I Blood; 1994 Jan; 83(2):426-34. PubMed ID: 8286741 [TBL] [Abstract][Full Text] [Related]
2. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model. Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679 [TBL] [Abstract][Full Text] [Related]
3. Recombinant single-chain immunotoxins against T and B cell leukemias. Kreitman RJ; Pastan I Leuk Lymphoma; 1994 Mar; 13(1-2):1-10. PubMed ID: 8025511 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin. Reiter Y; Kreitman RJ; Brinkmann U; Pastan I Int J Cancer; 1994 Jul; 58(1):142-9. PubMed ID: 8014011 [TBL] [Abstract][Full Text] [Related]
5. Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia. Kreitman RJ; Chaudhary VK; Kozak RW; FitzGerald DJ; Waldman TA; Pastan I Blood; 1992 Nov; 80(9):2344-52. PubMed ID: 1421405 [TBL] [Abstract][Full Text] [Related]
6. Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds. Kreitman RJ; Batra JK; Seetharam S; Chaudhary VK; FitzGerald DJ; Pastan I Bioconjug Chem; 1993; 4(2):112-20. PubMed ID: 7873642 [TBL] [Abstract][Full Text] [Related]
7. Accumulation of a recombinant immunotoxin in a tumor in vivo: fewer than 1000 molecules per cell are sufficient for complete responses. Kreitman RJ; Pastan I Cancer Res; 1998 Mar; 58(5):968-75. PubMed ID: 9500458 [TBL] [Abstract][Full Text] [Related]
8. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia. Kreitman RJ; Chaudhary VK; Waldmann T; Willingham MC; FitzGerald DJ; Pastan I Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8291-5. PubMed ID: 2236041 [TBL] [Abstract][Full Text] [Related]
9. Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptor. Kreitman RJ; Schneider WP; Queen C; Tsudo M; Fitzgerald DJ; Waldmann TA; Pastan I J Immunol; 1992 Oct; 149(8):2810-5. PubMed ID: 1401913 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of recombinant Fab and Fv immunotoxins on adult T-cell leukemia lymph node and blood cells in the presence of soluble interleukin-2 receptor. Saito T; Kreitman RJ; Hanada S; Makino T; Utsunomiya A; Sumizawa T; Arima T; Chang CN; Hudson D; Pastan I Cancer Res; 1994 Feb; 54(4):1059-64. PubMed ID: 8313362 [TBL] [Abstract][Full Text] [Related]
11. Characterization of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice. Benhar I; Pastan I Clin Cancer Res; 1995 Sep; 1(9):1023-9. PubMed ID: 9816075 [TBL] [Abstract][Full Text] [Related]
12. Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment. Reiter Y; Brinkmann U; Jung SH; Lee B; Kasprzyk PG; King CR; Pastan I J Biol Chem; 1994 Jul; 269(28):18327-31. PubMed ID: 7913461 [TBL] [Abstract][Full Text] [Related]
13. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. Batra JK; FitzGerald D; Gately M; Chaudhary VK; Pastan I J Biol Chem; 1990 Sep; 265(25):15198-202. PubMed ID: 2118522 [TBL] [Abstract][Full Text] [Related]
14. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo. Leland P; Taguchi J; Husain SR; Kreitman RJ; Pastan I; Puri RK Mol Med; 2000 Mar; 6(3):165-78. PubMed ID: 10965493 [TBL] [Abstract][Full Text] [Related]
15. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice. Reiter Y; Wright AF; Tonge DW; Pastan I Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511 [TBL] [Abstract][Full Text] [Related]
16. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Brinkmann U; Pai LH; FitzGerald DJ; Willingham M; Pastan I Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8616-20. PubMed ID: 1924323 [TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys. Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin. Batra JK; Jinno Y; Chaudhary VK; Kondo T; Willingham MC; FitzGerald DJ; Pastan I Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8545-9. PubMed ID: 2510169 [TBL] [Abstract][Full Text] [Related]
19. Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab' induce regression of subcutaneous human B-cell lymphoma in mice. Kreitman RJ; Hansen HJ; Jones AL; FitzGerald DJ; Goldenberg DM; Pastan I Cancer Res; 1993 Feb; 53(4):819-25. PubMed ID: 8428363 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia. Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]